Improved efficacy and tolerability of oral deferasirox by twice-daily dosing for patients with transfusion-dependent β-thalassemia

Chang H.-H, MENG-YAO LUMENG-YAO LUChang H.-HLiao Y.-M.Liao Y.-M.YUNG-LI YANGYang Y.-L.Chiou S.-S.SHIANN-TANG JOULin K.-H.Chang T.-T.Chang T.-T.2020-12-162020-12-1620111545-5009https://www.scopus.com/inward/record.uri?eid=2-s2.0-78651061167&doi=10.1002%2fpbc.22826&partnerID=40&md5=c22b56d3a463ade70e5e52ae70b62f00https://scholars.lib.ntu.edu.tw/handle/123456789/526438Improved efficacy and tolerability of oral deferasirox by twice-daily dosing for patients with transfusion-dependent β-thalassemiajournal article10.1002/pbc.22826210728252-s2.0-78651061167